Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Hidefumi Kinoshita
ResearcherPublications, citations & collaboration network
Hidefumi Kinoshita is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 366 works, 4,822 citations, an h-index of 30 and an i10-index of 122.
366
Works
4,822
Citations
30
h-index
122
i10-index
How has Hidefumi Kinoshita's publication output changed over time?
ScholarIQpublication output · 1994–2024
Output grew0% over the shown period — from 1 works in 1994 to 1 in 2024.
1
1
1
1
1
2
3
1
1
199419981999200020022005201720212024
What are the most-cited papers on Hidefumi Kinoshita?
ScholarIQmost cited works
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales‐Barrera, Aude Fléchon, Şeyda Gündüz, Yohann Loriot, Alejo Rodríguez‐Vida, Ronac Mamtani, Evan Y. Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, D. Cascallar, Mirta Varela, Mauricio Fernández Lazzaro, Diego Kaen, Gabriela Gatica, David Hugo Flores, Agustín Falco, Matias Molina, F. Van Aelst, Christof Vulsteke, Brieuc Sautois, Jean‐Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sérgio Jobim Azevedo, GISELE LOPES MARINHO, João Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, André P. Fay, Joel Gingerich, Yves Fradet, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, José Luis Leal, Francisco Francisco, Carolina Ibáñez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Fléchon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross‐Goupil, Stéphane Culine, Yohann Loriot, Gwénaëlle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David G. Pfister, Carsten Ohlman, Michael Stöeckle, Manfred P. Wirth, Anja Lorch, Guenter Niegisch, Peter J. Goebell, Martin Boegemann, Axel S. Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian A. Thomas, Thomas Hoefner, András Telekes, Judit Kósa, János Révész, Gyorgy Bodoky, Tibor Csőszi, András Csejtei, Lajos Géczi, Ágnes Ruzsa, Zsuzsanna Kolonics, József Erfán, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger
The Lancet Oncology. 2021655 CitationsOPEN ACCESS
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
David F. Jarrard, Hidefumi Kinoshita, Yan Shi, Carol Sandefur, Douglas Hoff, Lorraine F. Meisner, Chawnshang Chang, James G. Herman, William B. Isaacs, Najah T. Nassif
PubMed. 1998236 Citations
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
Hidefumi Kinoshita, Y. Shi, Carol Sandefur, L F Meisner, Chawnshang Chang, Aung Choon, Catherine Reznikoff, G. Steven Bova, Andreas Friedl, David F. Jarrard
PubMed. 2000188 Citations
Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma
Keisei Okamoto, Shinya Toyokuni, Kôji Uchida, Osamu Ogawa, Jun Takenewa, Y. Kakehi, Hidefumi Kinoshita, Yukari Hattori‐Nakakuki, Hiroshi Hiai, Osamu Yoshida
International Journal of Cancer. 1994179 Citations
Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient
Toru Yoshida, Hidefumi Kinoshita, Takehiko Segawa, Eijiro Nakamura, Takahiro Inoue, Yousuke Shimizu, Toshiyuki Kamoto, Osamu Ogawa
Cancer Research. 2005178 CitationsOPEN ACCESS
Related on ScholarIQ
Kansai Medical University
Institution
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Paper
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
Paper
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
Paper
Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma
Paper
Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient
Paper